Self-stigmatization and treatment preferences: Measuring the impact of treatment labels on choices for depression medications.

ABSTRACT:

Objective

To collect evidence on the possibility that patients with depression experience self-stigmatization based on label information for medications.

Methods

We developed a discrete-choice experiment (DCE) survey instrument that asked respondents to make choices between hypothetical treatments for major depressive disorder (MDD). We also included treatment type (antidepressants versus antipsychotics) and approved indications for the medication. The choice questions mimicked the information presented in product inserts and required systematic tradeoffs between treatment efficacy, treatment type, and indication. We calculated how many patients were willing to forgo efficacy to avoid treatments with information associated with self-stigmatization, and how much efficacy they

SUBMITTER: Gonzalez Sepulveda JM 

PROVIDER: S-EPMC11371228 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature